The antibody, known as 47D11, was created in a lab and can neutralize the spike protein found in SARS-CoV-2, the virus that causes COVID-19. Researchers are still not certain how the antibody neutralizes the spike protein.
The 47D11 antibody is known as a monoclonal antibody, or a lab-made antibody, which have increasingly been recognized as a promising drug form against infectious diseases, according to the report.
Though it is still early in the development of any potential drug, the antibody shows promise, the researchers concluded.
More articles on public health:
Now-dominant strain of coronavirus appears more contagious than original, new study finds
DMC hospital cleared by state, feds of reported infection control, nurse staffing violations
8 things Americans are thinking about COVID-19
